BlueCross BlueShield of South Carolina and its subsidiary BlueChoice® HealthPlan will cover testing to diagnose COVID-19 for its members when medically necessary and prescribed by health providers. Any subsequent needed care will be done in close coordination with federal, state and public health authorities.
The health insurers will cover members’ copays, co-insurance and deductibles to diagnose COVID-19 when consistent with the Centers for Disease Control and Prevention (CDC) guidelines, and where it is not covered as part of the Public Health Service response.
In addition, the companies will waive prior authorizations for diagnostic tests and for covered services that are medically necessary and consistent with CDC guidance for members diagnosed with COVID-19. Read More……..